TAG:
pathology labs
Scripps’ Tumor Board Finds Value in Digital Imaging of Slides
By Robert Michel | From the Volume XVI No. 14 – October 12, 2009 Issue
CEO Summary: When the Pathology Department at Scripps Memorial Hospital in La Jolla, California, was considering the purchase of a digital imaging system, it gained unlikely allies. Non-pathologist physicians participating in the department’s tumor boards advocated for the purchase afte…
Less Money for Labs Is International Trend
By R. Lewis Dark | From the Volume XVI No. 13 – September 21, 2009 Issue
TOO OFTEN THESE DAYS, labs are asked to accept less money. This is true in the United States and in many developed countries around the world. Many of you know that the latest version of the Senate health reform bill recently released by Max Baucus (D-Montana) calls for all providers to pay a “fee…
Using Lean at Henry Ford Transforms Pathology TAT
By Robert Michel | From the Volume XVI No. 11 – August 10, 2009 Issue
CEO SUMMARY: Long-standing work flow traditions in anatomic pathology provide fertile ground for improvement with Lean and similar process improvement methods. That was the case at Henry Ford Health System, where empowered teams in the pathology laboratory employed the principles…
CBL Path, Plus Diagnostics, Alpha Innotech, DNA Direct, Humana
By Robert Michel | From the Volume XVI No. 9 – June 29, 2009 Issue
NEW PATHOLOGY LABS OPEN ON EAST COAST TIMES MUST BE GOOD for anatomic pathology companies—at least two companies have each announced the opening of a new laboratory facility. On the East Coast, it was CBL Path, Inc., of Rye Brook, New York, which expanded. On May 29, it a…
Inverness Medical, ACON, LabInfotech, Kaiser Permenante
By Robert Michel | From the Volume XVI No. 5 – April 6, 2009 Issue
INVERNESS ACQUIRES TEST BUSINESS FROM ACON WITH A STRATEGY OF BECOMING DOMINANT in the consumer testing market and point-of- care (POC) testing sector, Inverness Medical Innovations, Inc., of Waltham, Massachusetts, has actively acquired companies a…
Local Labs Have Opportunities To Increase MC Patient Access
By Robert Michel | From the Volume XVI No. 3 – February 23, 2009 Issue
CEO SUMMARY: Although the nation’s two largest laboratory companies have achieved a dominant managed care position, opportunities remain for regional labs to do more business with managed care plans. Two experts provide an update of managed care pricing trends for labo…
July 7, 2008 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XV No. 9 – July 7, 2008 Issue
GI Pathology, PLLC, of Memphis, Tennessee, announced that it has contracted to be a national gastrointestinal (GI) pathology laboratory provider with CIGNA HealthCare of Hartford, Connecticut. It also has a five year, national provider contract with UnitedHea…
CMS Expected to Revise Condo Lab & TC/PC Rules
By Robert Michel | From the Volume XV No. 8 – June 16, 2008 Issue
CEO SUMMARY: Expectations are that the Centers for Medicare & Medicaid Services (CMS) will take further action to rein in anatomic pathology arrangements used by physicians to capture revenue from their patient referrals. This may happen as soon as next month, when CMS publishes the 2…
Heeding the Lessons of Market Competition
By R. Lewis Dark | From the Volume XIV No. 13 – September 17, 2007 Issue
COMPETITION FOR LAB TESTING DOLLARS IS THROWING NEW CURVEBALLS at both clinical labs and pathology group packages. Failure to spot these developments and respond to them now will have swift financial consequences. In this issue of THE DARK REPORT, readers will notice how we’ve identified market th…
An Economic Perspective On Discounted PC Deals
By Robert Michel | From the Volume XIV No. 13 – September 17, 2007 Issue
CEO SUMMARY: By opening their own in-office pathology laboratories, specialist physicians are undermining a long-established referral relationship with the pathology profession. Pathologists are debating the merits of this market-based trend and its effect on their profession. However thi…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized